No Data
No Data
Proteomics International Unit's Muscle Damage Test Shows Potential in Study of Athletes
Australian Shares Inch Down Amid Wall Street Losses; Astral Resources Submits Proposal to Acquire Maximus Resources
Proteomics International Validates Endometriosis Biomarker for Diagnostic Test; Shares Climb 22%
Proteomics International Laboratories Ltd: Proteomics receives $2.16 million in R&D tax incentive
ASX Small-Cap Stocks to Watch
Proteomics Investors Face 'Considerable Unknowns' After Kidney Diagnostics License Canceled, Says Euroz Hartleys
No Data